Mandashi invests in the Superbio machine learning platform
Mandashi is pleased to announce its latest investment in Superbio.
Superbio is a machine learning platform designed specifically for bioinformatics, enabling scientists and researchers to quickly develop and share deep analysis of their data, and therefore enable the rapid turnaround of experimental results.
Dr Andy Evans, Director of Mandashi, said: "We were very impressed with the Superbio team's vision of providing a low code platform that can be used by scientists to analyse their data without the need for complex coding. By bringing the benefits of low code machine learning to the scientific community, Superbio is truly democratising the value of bioinformatics".